Summary

Low-dose isotretinoin reduced the number of acne lesions in adult patients with acne vulgaris beginning at 4 weeks and continuing through 32 weeks, with 40% of patients remaining acne free for 3 years. This article discusses data from an unpublished follow-up study that evaluated low-dose isotretinoin for the treatment of adult acne.